BOLD
Audentes Therapeutics, Inc
BOLD
BOLD
Delisted
BOLD was delisted on the 14th of January, 2020.
188 hedge funds and large institutions have $2.57B invested in Audentes Therapeutics, Inc in 2019 Q4 according to their latest regulatory filings, with 86 funds opening new positions, 47 increasing their positions, 39 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
21% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 39
85% less call options, than puts
Call options by funds: $12.5M | Put options by funds: $82.4M
Holders
188
Holding in Top 10
19
Calls
$12.5M
Puts
$82.4M
Top Buyers
| 1 | +$95.4M | |
| 2 | +$87.1M | |
| 3 | +$81.3M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$71.2M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$61.8M |
Top Sellers
| 1 | -$139M | |
| 2 | -$130M | |
| 3 | -$84.8M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$69.8M |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$66.1M |